The Nasdaq-listed firm will change its ticker to LITS on September 11, 2025, while Litecoin creator Charlie Lee joins its board of directors.
MEI Pharma announced a corporate rebranding to Lite Strategy, effective September 11, 2025, with its stock ticker changing from MEIP to LITS. The Nasdaq-listed company also confirmed that Charlie Lee, the creator of Litecoin, has been appointed to its board of directors.